These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24316434)

  • 1. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement.
    Gonzalez-Lima F; Barksdale BR; Rojas JC
    Biochem Pharmacol; 2014 Apr; 88(4):584-93. PubMed ID: 24316434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological and psychological applications of transcranial lasers and LEDs.
    Rojas JC; Gonzalez-Lima F
    Biochem Pharmacol; 2013 Aug; 86(4):447-57. PubMed ID: 23806754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.
    Rojas JC; Bruchey AK; Gonzalez-Lima F
    Prog Neurobiol; 2012 Jan; 96(1):32-45. PubMed ID: 22067440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase.
    Atamna H; Kumar R
    J Alzheimers Dis; 2010; 20 Suppl 2():S439-52. PubMed ID: 20463399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.
    Yang L; Youngblood H; Wu C; Zhang Q
    Transl Neurodegener; 2020 Jun; 9(1):19. PubMed ID: 32475349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dying of the light: mitochondrial failure in Alzheimer's disease.
    Young-Collier KJ; McArdle M; Bennett JP
    J Alzheimers Dis; 2012; 28(4):771-81. PubMed ID: 22057028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
    Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
    Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report.
    Horner S; Berger L; Gibas K
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101777. PubMed ID: 32305654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
    Arendash GW
    J Alzheimers Dis; 2012; 32(2):243-66. PubMed ID: 22810103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.
    Tucker D; Lu Y; Zhang Q
    Mol Neurobiol; 2018 Jun; 55(6):5137-5153. PubMed ID: 28840449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
    Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
    Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.
    Yang SH; Li W; Sumien N; Forster M; Simpkins JW; Liu R
    Prog Neurobiol; 2017 Oct; 157():273-291. PubMed ID: 26603930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating cognitive impairment with transcranial low level laser therapy.
    de la Torre JC
    J Photochem Photobiol B; 2017 Mar; 168():149-155. PubMed ID: 28219828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue and Alzheimer's disease.
    Oz M; Lorke DE; Petroianu GA
    Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
    Inazu M; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain aging and Alzheimer's disease; use it or lose it.
    Swaab DF; Dubelaar EJ; Hofman MA; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 2002; 138():343-73. PubMed ID: 12432778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.